3-iodobenzylguanidine has been researched along with neuropeptide y in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aubert, B; Bosq, J; Comoy, E; Fonseca, E; Ghillani, PP; Gicquel, C; Lumbroso, J; Schlumberger, M; Tenenbaum, F; Travagli, JP | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and neuropeptide y
Article | Year |
---|---|
Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Calcitonin; Calcitonin Gene-Related Peptide; Catecholamines; Child; Chromogranin A; Chromogranins; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neoplasm Metastasis; Neuropeptide Y; Pheochromocytoma; Phosphopyruvate Hydratase; Protein Precursors; S100 Proteins; Tomography, Emission-Computed; Treatment Outcome | 1992 |